4//SEC Filing
Serafin Andrew 4
Accession 0001415889-24-001870
CIK 0001802665other
Filed
Jan 25, 7:00 PM ET
Accepted
Jan 26, 4:54 PM ET
Size
8.1 KB
Accession
0001415889-24-001870
Insider Transaction Report
Form 4
Serafin Andrew
CHIEF STRATEGY OFFICER
Transactions
- Award
Stock Option
2024-01-24+47,750→ 47,750 totalExercise: $30.69Exp: 2034-01-24→ Common Stock (47,750 underlying) - Award
Restricted Stock Unit
2024-01-24+10,000→ 10,000 total→ Common Stock (10,000 underlying)
Footnotes (2)
- [F1]The stock option vests with respect to 25% of the underlying shares on January 24, 2025, with the remaining shares vesting ratably on a quarterly basis thereafter until the fourth anniversary of the grant date, subject to the Reporting Person's continued service through each applicable vesting date.
- [F2]The restricted stock units shall vest in four equal annual installments beginning on January 24, 2025, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date.
Documents
Issuer
Harmony Biosciences Holdings, Inc.
CIK 0001802665
Entity typeother
Related Parties
1- filerCIK 0001821460
Filing Metadata
- Form type
- 4
- Filed
- Jan 25, 7:00 PM ET
- Accepted
- Jan 26, 4:54 PM ET
- Size
- 8.1 KB